Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

CPRXCPRX
Showing 8 of 22 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in CATALYST PHARMACEUTICALS INC

Qube Research & Technologies Ltd holds 2.3M shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $70.9M as of 2026-Q2. The position was increased (+446.3% shares). CPRX represents 0.1% of Qube Research & Technologies Ltd's portfolio.

Current Value

$70.9M

Current Shares

2.3M

Total Value Change

+$57.6M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.3M
+446.3%
$70.9M0.1%$31.43
48
2026-Q1
Decreased
412,666
-15.3%
$10.2M0.0%$23.92
0
2025-Q4
Decreased
487,135
-40.7%
$11.4M0.0%$23.29
0
2025-Q3
Decreased
821,202
-19.1%
$16.2M0.0%$19.55
0
2025-Q2
Increased
1M
+33.4%
$22M0.0%$21.78
37
2025-Q1
Increased
760,296
+15.3%
$18.4M0.0%$24.69
33
2024-Q4
Decreased
659,252
-1.2%
$13.8M0.0%$21.07
0
2024-Q3
Increased
667,240
+418.3%
$13.3M0.0%$19.56
45

Other major holders of CPRX: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used